XML 34 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Unaudited Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 251,369 $ 247,527
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 17,983 16,500
Share-based compensation 11,992 11,769
Non-cash contribution to 401(k) plan 4,274 2,945
Deferred income tax provision 2,765 3,925
Other income from investment in unconsolidated entity (7,939) (8,491)
Other, net 1,260 927
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable (102,813) (126,181)
Inventories (74,448) (50,566)
Accounts payable and other liabilities 99,627 (23,286)
Other, net (6,539) (5,004)
Net cash provided by operating activities 197,531 70,065
Cash flows from investing activities:    
Business acquisitions, net of cash acquired (47,343) (5,828)
Capital expenditures (14,007) (12,897)
Investment in unconsolidated entity (4,940) (3,760)
Proceeds from sale of property and equipment 1,295 143
Net cash used in investing activities (64,995) (22,342)
Cash flows from financing activities:    
Dividends on Common and Class B common stock (180,454) (154,951)
Purchase of additional ownership from non-controlling interest (32,400)  
Repurchases of common stock to satisfy employee withholding tax obligations (1,528) (3,782)
Net repayments of other long-term obligations (920) (182)
Distributions to non-controlling interest   (2,178)
Proceeds from non-controlling interest for investment in unconsolidated entity 988 752
Net proceeds from issuances of common stock 7,480 5,979
Proceeds from non-controlling interest for investment in Peirce-Phelps, Inc. 17,000  
Net proceeds under revolving credit agreement 34,100 94,600
Net cash used in financing activities (155,734) (59,762)
Effect of foreign exchange rate changes on cash and cash equivalents 454 (845)
Net decrease in cash and cash equivalents (22,744) (12,884)
Cash and cash equivalents at beginning of period 82,894 80,496
Cash and cash equivalents at end of period 60,150 67,612
Peirce-Phelps, Inc.    
Supplemental cash flow information:    
Common stock issued 58,638  
Dunphey & Associates Supply Co., Inc.    
Supplemental cash flow information:    
Common stock issued $ 7,450  
Alert Labs Inc    
Supplemental cash flow information:    
Common stock issued   $ 8,180